Stephen D Smith Selected Research

Stephen D Smith Research Topics

Disease

13	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 11/2023 - 03/2010
12	Lymphoma (Lymphomas) 01/2023 - 10/2009
11	Neoplasms (Cancer) 02/2024 - 01/2012
11	B-Cell Lymphoma (Lymphoma, B Cell) 12/2023 - 01/2017
8	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2023 - 11/2018
8	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023 - 01/2010
7	Hodgkin Disease (Hodgkin's Disease) 01/2023 - 12/2015
2	Thrombocytopenia (Thrombopenia) 12/2022 - 01/2018
2	Disease Progression 01/2018 - 08/2011
1	Hypertension (High Blood Pressure) 02/2024
1	Cytopenia 12/2022
1	Anemia 12/2022
1	Neutropenia 12/2022
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2022
1	Febrile Neutropenia 08/2021
1	Sepsis (Septicemia) 08/2021
1	Pulmonary Embolism 08/2021
1	AIDS-Related Complex (ARC) 01/2021
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2019
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2019
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019
1	Multiple Myeloma 01/2018
1	Pathologic Complete Response 02/2016
1	Residual Neoplasm 02/2016
1	Amyloidosis 10/2014
1	Immunoglobulin Light-chain Amyloidosis 10/2014
1	Melanoma (Melanoma, Malignant) 08/2012
1	Chordoma 08/2012
1	Lymphocytosis 08/2011
1	Stomatitis 01/2010

Drug/Important Bio-Agent (IBA)

9	Rituximab (Mabthera)FDA Link 01/2023 - 01/2017
7	Etoposide (VP 16)FDA LinkGeneric 01/2023 - 01/2010
6	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2020
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 01/2010
5	Agammaglobulinaemia Tyrosine KinaseIBA 02/2024 - 01/2018
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 08/2012
4	acalabrutinibIBA 07/2023 - 01/2018
4	Vincristine (Oncovin)FDA LinkGeneric 01/2023 - 08/2012
4	Prednisone (Sone)FDA LinkGeneric 01/2023 - 12/2017
4	Bendamustine Hydrochloride FDA Link 01/2021 - 11/2018
3	ibrutinibIBA 02/2024 - 11/2020
3	polatuzumab vedotinIBA 12/2023 - 01/2021
3	axicabtagene ciloleucelIBA 12/2022 - 01/2020
3	Brentuximab VedotinIBA 08/2021 - 12/2015
3	Ifosfamide FDA LinkGeneric 08/2021 - 08/2012
3	Bortezomib (Velcade)FDA Link 01/2019 - 10/2014
2	Immunoconjugates (Immunoconjugate)IBA 11/2023 - 11/2021
2	Immune Checkpoint InhibitorsIBA 10/2023 - 01/2023
2	pembrolizumabIBA 01/2023 - 01/2020
2	Chimeric Antigen ReceptorsIBA 12/2022 - 12/2022
2	Dexamethasone (Maxidex)FDA LinkGeneric 12/2022 - 01/2018
2	Carboplatin (JM8)FDA LinkGeneric 08/2021 - 11/2018
2	IceIBA 08/2021 - 11/2018
2	Melphalan (Alkeran)FDA LinkGeneric 01/2021 - 10/2014
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021 - 01/2019
1	Antihypertensive Agents (Antihypertensives)IBA 02/2024
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2022
1	N- (1- (7- fluoro- 2- (pyridin- 2- yl)quinolin- 3- yl)ethyl)- 9H- purin- 6- amineIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 11/2021
1	Phosphotransferases (Kinase)IBA 11/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 08/2021
1	Alanine Transaminase (SGPT)IBA 08/2021
1	Radioisotopes (Radionuclides)IBA 01/2021
1	Carmustine (FIVB)FDA Link 01/2021
1	zanubrutinibIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Yttrium-90IBA 01/2021
1	selinexorIBA 10/2020
1	enzastaurinIBA 05/2020
1	B7-H1 AntigenIBA 01/2020
1	Androgen Receptors (Androgen Receptor)IBA 01/2020
1	ixazomibIBA 01/2018
1	Lenalidomide (CC 5013)FDA Link 01/2018
1	Everolimus FDA Link 01/2018
1	RetinoidsIBA 01/2017
1	FenretinideIBA 01/2017
1	PlatinumIBA 12/2015
1	CollagenIBA 08/2012
1	Protein Kinase CIBA 08/2012
1	Protein Kinases (Protein Kinase)IBA 08/2012
1	IntegrinsIBA 08/2012
1	Protons (Proton)IBA 08/2012
1	DNA (Deoxyribonucleic Acid)IBA 01/2012
1	Cyclin D1IBA 08/2011

Therapy/Procedure

20	Therapeutics 11/2023 - 01/2010
9	Stem Cell Transplantation 08/2021 - 10/2009
7	Drug Therapy (Chemotherapy) 02/2024 - 08/2012
2	Immunotherapy 01/2023 - 01/2021
2	Cell Transplantation 11/2022 - 01/2021
2	Radioimmunotherapy 11/2022 - 12/2015
2	Homologous Transplantation 11/2022 - 01/2021
1	VAP-cyclo protocol 01/2023
1	Platelet Transfusion (Blood Platelet Transfusions) 12/2022
1	Aftercare (After-Treatment) 12/2022
1	Conservative Treatment 01/2022
1	Radiotherapy 01/2020
1	Induction Chemotherapy 02/2016
1	Autologous Transplantation 12/2015
1	Combination Drug Therapy (Combination Chemotherapy) 08/2012